Haley Emery, Luke Natalie, Mathur Mohit, Festa Richard A, Wang Jimin, Jiang Yan, Anderson Lori A, Baunoch David
Department of Clinical Research, Pathnostics, Irvine, CA, USA.
Department of Medical Affairs, Pathnostics, Irvine, CA, USA.
Res Rep Urol. 2024 Jan 9;16:19-29. doi: 10.2147/RRU.S443361. eCollection 2024.
Many emerging uropathogens are currently identified by multiplex polymerase chain reaction (M-PCR) in suspected UTI cases. Standard urine culture (SUC) has significantly lower detection rates, raising questions about whether these organisms are associated with UTIs and truly cause inflammation.
To determine if microbes detected by M-PCR were likely causative of UTI by measuring inflammatory biomarkers in the urine of symptomatic patients.
Midstream voided urine was collected from subjects ≥60 years presenting to urology clinics with symptoms of UTI (n = 1132) between 01/2023 and 05/2023. Microbe detection was by M-PCR and inflammation-associated biomarker (neutrophil gelatinase-associated lipocalin, interleukin 8, and interleukin 1β) was by enzyme-linked immunosorbent assay. Biomarker positivity was measured against individual and groups of organisms, and non- cases, emerging uropathogens, monomicrobial and polymicrobial cases.
Distributions were compared using 2-sample Wilcoxon Rank Sum test with 2-tailed p-values < 0.05 considered statistically significant.
M-PCR was positive in 823 (72.7%) specimens with 28 of 30 (93%) microorganisms/groups detected. Twenty-six of twenty-eight detected microorganisms/groups (93%) had ≥2 biomarkers positive in >66% of cases. Both non- cases and cases had significant biomarker positivity (p < 0.05). Limitations were that a few organisms had low prevalence making inferences about their individual significance difficult.
The majority of microorganisms identified by M-PCR were associated with active inflammation measured by biomarker positivity, indicating they are likely causative of UTIs in symptomatic patients. This includes emerging uropathogens frequently not detected by standard urine culture.
目前,在疑似尿路感染(UTI)病例中,许多新出现的尿路病原体是通过多重聚合酶链反应(M-PCR)鉴定出来的。标准尿培养(SUC)的检出率明显较低,这引发了关于这些微生物是否与UTI相关以及是否真的会引起炎症的疑问。
通过测量有症状患者尿液中的炎症生物标志物,确定M-PCR检测到的微生物是否可能是UTI的病因。
设计、地点和参与者:2023年1月至2023年5月期间,从≥60岁到泌尿外科诊所就诊且有UTI症状的受试者(n = 1132)中收集中段尿。微生物检测采用M-PCR,炎症相关生物标志物(中性粒细胞明胶酶相关脂质运载蛋白、白细胞介素8和白细胞介素1β)检测采用酶联免疫吸附测定。针对单个和一组生物体以及非病例、新出现的尿路病原体、单一微生物和多种微生物病例测量生物标志物阳性率。
使用双样本Wilcoxon秩和检验比较分布情况,双侧p值<0.05被认为具有统计学意义。
823份(72.7%)标本的M-PCR呈阳性,检测到的30种微生物/菌群中有28种(93%)。检测到的28种微生物/菌群中有26种(93%)在>66%的病例中≥2种生物标志物呈阳性。非病例和病例的生物标志物阳性率均有统计学意义(p < 0.05)。局限性在于一些生物体的患病率较低,难以推断其个体意义。
通过M-PCR鉴定出的大多数微生物与生物标志物阳性所测量的活动性炎症相关,表明它们可能是有症状患者UTI的病因。这包括标准尿培养经常检测不到的新出现的尿路病原体。